Advertisement

Sign up for our newsletter

Advertisement

Movistar rider suspended for adverse analytical finding in his biological passport

Joe Robinson
28 Jun 2018

Jaime Roson receives suspension for adverse analytical finding in January 2017 when at Caja Rural

Young Moivstar climbing talent Jaime Roson Garcia has been provisionally suspended due to an adverse analytical finding in his biological passport. The adverse test finding was returned by Roson while riding for Spanish ProContinental team Caja Rural in January 2017.

It is yet to be announced what substance Roson has been flagged for.

In a press release, Movistar stated that 'the Abarca Sports organisation received yesterday evening, Wednesday 27th June 2018, an official communication from the Union Cycliste Internationale (UCI) where it was notified of the provisional suspension of its rider Jaime Rosón García, due to an adverse analytical finding in his biological passport, dated January 2017, nearly one year before joining the team.'

The team then went on to state that since joining the team 'the rider’s behaviour, health analytics and biological passport values have been irreproachable' and therefore the team will cooperate with the rider in finding an explanation for the findings.

However, the team has also announced that as 'an advocate of cycling’s credibility and fair play, and following the UCI’s Anti-Doping Rules' that Roson will be suspended with immediate effect.

Roson has been hotly tipped as one of Spain's most promising climbing talents with his impressive 2017 season earning him a contract in the WorldTour.

During this season, the 25-year-old secured second overall at the Tour of Croatia and fifth at the Vuelta a Burgos before racing the Vuelta a Espana.

In his debut season for Movistar this year, Roson even managed to secure a maiden win with the team, taking the General Classification at the Vuelta Aragon.

Roson's last race was the Criterium de Dauphine in which he finished 51st on GC in support of teammate Marc Soler. 

Read more about: